2
Development of mucoadhesive drug delivery systems intended for Development of mucoadhesive drug delivery systems intended for Development of mucoadhesive drug delivery systems intended for Development of mucoadhesive drug delivery systems intended for buccal administration buccal administration buccal administration buccal administration Prof.ssa Luisa Montanari – University of Milano – Consorzio TEFARCO Innova New low-swellable bioadhesive materials were obtained by salification with alkali of the carboxylic groups of well-established methacrylic copolymers, namely Eudragit®L100 and Eudragit®S100 (XPMM). The flexibility of application of these materials has been demonstrated preparing buccoadhesive tablets and mucoadhesive microparticulate delivery systems containing nifedipine or piroxicam. The compliance as well as the in vivo permanence time of the mucoadhesive tablets has been considered satisfactory. The preparation of microparticles by spray-drying improved the apparent solubility and the dissolution rate of the loaded drugs. 1. Description of the product 1. Description of the product 1. Description of the product 1. Description of the product Buccoadhesive drug delivery systems have been designed to prolong the drug residence time in the oral cavity. The commonly used mucoadhesive materials swell upon contact with aqueous media and the outer viscous layer compromises patients’ compliance. It has been demonstrated that new low-swellable mucoadhesive materials can be achieved by neutralization of pharmaceutical approved methacrylic copolymers with alkali. The versatility of these polymethylmethacrylate salts was successfully exploited to design tablets, patches and fast-dissolving microparticulate systems. Their dissolution rate and adhesive mechanisms of these materials can be easily modified by addition of other excipients. 2. I 2. I 2. I 2. Innovative aspect of the product nnovative aspect of the product nnovative aspect of the product nnovative aspect of the product The innovation of this product consists on conferring mucoadhesive properties to pharmaceutical approved polymethylmethacrylate by neutralization with alkali, without requiring a characterization with regards to the regulatory aspects. 3. Main advantages of the offer 3. Main advantages of the offer 3. Main advantages of the offer 3. Main advantages of the offer These novel mucoadhesive polymers are promising materials to develop a platform able to meet different needs in the formulation of mucoadhesive dosage forms. Microphotography of Na PMM 0 1 2 3 4 5 6 7 8 0,00 0,25 0,50 0,75 1,00 Elongation (mm) Detachment force (N) NaPMM KPMM Carbopol 934 HPMC K4M Mucoadhesive properties. Detachment force pattern from mucin as a function of elongation.

Development of mucoadhesive drug delivery systems intended

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Development of mucoadhesive drug delivery systems intended

Development of mucoadhesive drug delivery systems intended for Development of mucoadhesive drug delivery systems intended for Development of mucoadhesive drug delivery systems intended for Development of mucoadhesive drug delivery systems intended for buccal administrationbuccal administrationbuccal administrationbuccal administration

Prof.ssa Luisa Montanari – University of Milano – Consorzio TEFARCO Innova

New low-swellable bioadhesive materials were obtained by salification with alkali of the carboxylic groups

of well-established methacrylic copolymers, namely Eudragit®L100 and Eudragit®S100 (XPMM).

The flexibility of application of these materials has been demonstrated preparing buccoadhesive tablets and

mucoadhesive microparticulate delivery systems containing nifedipine or piroxicam.

The compliance as well as the in vivo permanence time of the mucoadhesive tablets has been considered

satisfactory.

The preparation of microparticles by spray-drying improved the apparent solubility and the dissolution rate

of the loaded drugs.

1. Description of the product1. Description of the product1. Description of the product1. Description of the product

Buccoadhesive drug delivery systems have been designed to prolong the drug residence time in the oral

cavity. The commonly used mucoadhesive materials swell upon contact with aqueous media and the outer

viscous layer compromises patients’ compliance.

It has been demonstrated that new low-swellable mucoadhesive materials can be achieved by neutralization

of pharmaceutical approved methacrylic copolymers with alkali.

The versatility of these polymethylmethacrylate salts was successfully exploited to design tablets, patches

and fast-dissolving microparticulate systems. Their dissolution rate and adhesive mechanisms of these

materials can be easily modified by addition of other excipients. 2. I2. I2. I2. Innovative aspect of the product nnovative aspect of the product nnovative aspect of the product nnovative aspect of the product

The innovation of this product consists on conferring mucoadhesive properties to pharmaceutical approved

polymethylmethacrylate by neutralization with alkali, without requiring a characterization with regards to

the regulatory aspects.

3. Main advantages of the offer3. Main advantages of the offer3. Main advantages of the offer3. Main advantages of the offer

These novel mucoadhesive polymers are promising materials to develop a platform able to meet different

needs in the formulation of mucoadhesive dosage forms.

Microphotography of Na PMM

0

1

2

3

4

5

6

7

8

0,00 0,25 0,50 0,75 1,00Elongation (mm)

Det

achm

ent f

orce

(N

)

NaPMMKPMMCarbopol 934HPMC K4M

Mucoadhesive properties. Detachment force pattern from mucin as a function of elongation.

Page 2: Development of mucoadhesive drug delivery systems intended

4. Technology key words4. Technology key words4. Technology key words4. Technology key words

Mucoadhesive material, polymethylmethacrylate salts, microparticulate system, buccal patches. 5. 5. 5. 5. Current Stage of Development Current Stage of Development Current Stage of Development Current Stage of Development

Work in progress – Tested in field 6. Intellectual Property Rights6. Intellectual Property Rights6. Intellectual Property Rights6. Intellectual Property Rights

The product of the research is covered by patent.

Technical and scientific pubTechnical and scientific pubTechnical and scientific pubTechnical and scientific publicationslicationslicationslications

P.Minghetti, B.Pacchetti, L.Montanari, C.Ronchi, F.Berlati, “Buccoadhesive tablets for the slow delivery of

cetylpyridinium chloride: design and in vitro/in vivo analysis”, Bollettino Chimico Farmaceutico 7: 543-548,

1997.

P.Minghetti, A.Colombo, L.Montanari, G.M.Gaeta, F.Gombos, “Buccoadhesive slow-release tablets of

acitretin: design and in vivo evaluation”, Int. J. Pharm. 169(2):195-202, 1998.

F.Cilurzo, P.Minghetti, F.Selmin, A.Casiraghi, L.Montanari. “Polymethacrylate salts as new low-swellable

mucoadhesive materials”, J. Control. Rel. 88(1): 43-53, 2003.

F.Cilurzo, F.Selmin, P.Minghetti, I.Rimoldi, F.Demartin, L.Montanari, “Fast-dissolving mucoadhesive

microparticulate delivery system containing piroxicam”, Eur. J. Pharm. Sci. 24(4):355-361, 2005.

F.Cilurzo, F. Selmin, P. Minghetti, L. Montanari, The effects of bivalent inorganic salts on the mucoadhesive

performace of a polymethylmethacrylate sodium salt, Int. J. Pharm. 301(1-2): 62-70, 2005.

CONTACTCONTACTCONTACTCONTACT

[email protected]

Tel.: +39 0521 905073 Fax: +39 0521 905006